CHEK2 and breast carcinoma: In conclusion, functional analysis suggest that two CHEK2 variants found in our cohort (p.Glu239Lys and p.Pro484Leu) are likely to affect CHK2 activity in vivo and be associated with increased risk of breast cancer.